Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas

[1]  B. Koçak,et al.  Radiomics with artificial intelligence: a practical guide for beginners. , 2019, Diagnostic and interventional radiology.

[2]  A. Barnes,et al.  Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping. , 2019, European journal of radiology.

[3]  Liang Han,et al.  MRI texture analysis based on 3D tumor measurement reflects the IDH1 mutations in gliomas - A preliminary study. , 2019, European journal of radiology.

[4]  S.s. Lu,et al.  Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas. , 2019, Clinical radiology.

[5]  Wenya Linda Bi,et al.  Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas , 2019, Journal of Neuro-Oncology.

[6]  Sotirios Bisdas,et al.  Texture analysis- and support vector machine-assisted diffusional kurtosis imaging may allow in vivo gliomas grading and IDH-mutation status prediction: a preliminary study , 2018, Scientific Reports.

[7]  Jong-Hee Chang,et al.  Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas , 2018, American Journal of Neuroradiology.

[8]  Andriy Fedorov,et al.  Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.

[9]  Yuanyuan Wang,et al.  Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma , 2017, European Radiology.

[10]  Wei Cao,et al.  Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma , 2017, Scientific Reports.

[11]  G. Reifenberger,et al.  European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.

[12]  Geoffrey G. Zhang,et al.  Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels , 2017, Medical physics.

[13]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[14]  W. Wick,et al.  Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression , 2016, American Journal of Neuroradiology.

[15]  K. Yamashita,et al.  MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status , 2016, American Journal of Neuroradiology.

[16]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[17]  S. Heiland,et al.  IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma , 2015, Scientific Reports.

[18]  Ryuta Saito,et al.  Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas , 2015, Brain Tumor Pathology.

[19]  Robert J. Gillies,et al.  Test–Retest Reproducibility Analysis of Lung CT Image Features , 2014, Journal of Digital Imaging.

[20]  S. Qi,et al.  Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms , 2014, Oncology letters.

[21]  G. Reifenberger,et al.  Molecular neuro-oncology in clinical practice: a new horizon. , 2013, The Lancet. Oncology.

[22]  Hong Wu,et al.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy , 2012, Journal of Neuro-Oncology.

[23]  Yan Ding,et al.  IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma , 2012, Cancer science.

[24]  O. Chinot,et al.  Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis , 2010, Acta Neuropathologica.

[25]  Sylvain Arlot,et al.  A survey of cross-validation procedures for model selection , 2009, 0907.4728.

[26]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[27]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[28]  Anil K. Jain,et al.  Texture classification and segmentation using multiresolution simultaneous autoregressive models , 1992, Pattern Recognit..

[29]  Raymond Y Huang,et al.  Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas , 2017, Neuro-oncology.

[30]  Artur Klepaczko,et al.  MaZda – A Framework for Biomedical Image Texture Analysis and Data Exploration , 2017 .

[31]  David T. W. Jones,et al.  ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma , 2014, Acta Neuropathologica.

[32]  Benjamin M. Ellingson,et al.  Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics , 2014, Current Neurology and Neuroscience Reports.

[33]  Bernard Fertil,et al.  Texture indexes and gray level size zone matrix. Application to cell nuclei classification , 2009 .